Skip to main content
. 2021 Jun 25;35(1):99–111. doi: 10.1007/s40620-021-01100-3

Fig. 2.

Fig. 2

Laboratory data, PEEP and hemodynamics in patients who did or did not develop AKI. Trend in A creatinine, B C-reactive protein, C D-Dimer, D mean arterial pressure (MAP), E norepinephrine dose, F PEEP; G creatinine levels over time in patients treated with low (n = 31), medium (n = 32) or high (n = 32) PEEP. Two-way ANOVA. **p < 0.001, *p < 0.01, #p < 0.05. All data represent mean ± SEM